Pharmacological Correction of Experimental Acute Toxic Hepatitis
https://doi.org/10.18499/2225-7357-2019-8-1-49-54
Abstract
The aim of study was to develop new methods of treatment of acute toxic hepatitis. To achieve this objective, the authors investigated dynamics of pathological changes in the hepatic tissue under acute intoxication followed by the pharmacological correction with sodium hypochlorite.
Material and methods. The study included 45 male rats that were subjected to the experimental simulation of acute toxic hepatosis. Group 1 included intact animals; group 2 included animals that were intragastrically administered allyl alcohol resulting in acute toxic hepatosis; group 3 included rats with acute toxic hepatosis caused by allyl alcohol introduction that was corrected by sodium hypochlorite; group 4 included animals with acute toxic hepatosis corrected by essentiale N; group 5 included animals with acute toxic hepatosis corrected by the combined application of sodium hypochlorite and essentiale N. On the 6th day the animals were removed from the experiment with the followed histological examination of the hepatic tissue.
Results. The introduction of allyl alcohol was accompanied by significant changes in hepatocytes expressed by dystrophic, necrotic processes and circulatory disorders of the hepatic lobules. Pharmacological correction by sodium hypochlorite, essential H, or their combination did not result in the complete histological recovery of hepatocytes; however, the degree of fatty degeneration decreased significantly under the influence of sodium hypochlorite or its combination with essentiale N.
Conclusions. The application of sodium hypochlorite as a monotherapy or in combination with essential N in acute toxic hepatitis has allowed to relieve the severity of fatty liver disease. 0.03% solution of sodium hypochlorite can be effective as both - an independent method for treating acute toxic hepatitis, and in combination with other hepatoprotectors.
About the Authors
R. G. Myazin
Volgograd State Medical University, Volgograd
Russian Federation
Russian Federation
Roman Myazin
pl. Pavshikh bortsov, 1, Volgograd, 400131
G. L. Snigur
Volgograd State Medical University, Volgograd
Russian Federation
Russian Federation
D. N. Emel'yanov
Volgograd State Medical University, Volgograd
Russian Federation
Russian Federation
M. V. Chernyshova
Volgograd State Medical University, Volgograd
Russian Federation
Russian Federation
References
1. Венгеровский А. И., Маркова И. В. Доклиническое изучение гепатозащитных средств. Ведомости Фармакологического Комитета. 1999; 2: 9–12 [Vengerovskii AI, Markova IV. Doklinicheskoe izuchenie gepatozashchitnykh sredstv. Vedomosti Farmakologicheskogo Komiteta. 1999;(2):9–12] (in Russian).
2. Голиков С. Н., Саноцкий И. В., Тиунов Л. А. Общие механизмы токсического действия. М.; 1986. 280 [Golikov SN, Sanotskii IV, Tiunov LA. Obshchie mekhanizmy toksicheskogo deistviya. Moscow; 1986] (in Russian).
3. Емельянов Д. Н., Мязин Р. Г. Оценка влияния терапии гипохлоритом натрия на перекисное окисление липидов, антиоксидантную защиту, синдромы цитолиза и холестаза у больных токсическими гепатитами. Вестник АГИУВ. 2013;
4. : 79–81 [Yemelyanov DN, Myazin RG. Assessment of influence of therapy by sodium hypochlorite on perekisny oxidation of lipids, antioxidatic protection, syndromes of cytolysis and a cholestasia at patients with toxic hepatitises. Herald of Almaty State Institute of Advanced Medical Education. 2013;(4):79–81] (in Russian).
5. Ивашкин В. Т. Болезни печени и желчевыводящих путей: Руководство для врачей. М.; 2005. 536 [Ivashkin VT. Bolezni pecheni i zhelchevyvodyashchikh putei: Rukovodstvo dlya vrachei. Moscow; 2005] (in Russian).
6. Коржевский Д. Э., Гиляров А. В. Основы гистологической техники. СПб.: СпецЛит; 2010. 95 [Korzhevskii DE, Gilyarov AV. Osnovy gistologicheskoi tekhniki. Saint Petersburg: SpetsLit; 2010] (in Russian).
7. Лопаткин Н. А., Лопухин Ю. М. Эфферентные методы в медицине. М.; 1989. 352 [Lopatkin NA, Lopukhin YuM. Efferentnye metody v meditsine. Moscow; 1989].
8. Мязин Р. Г. Патент РФ № 2275921; 2006 [Myazin RG. Patent RF № 2275921; 2006]. URL: https://patents.google.com/patent/RU2275921C2/ru (дата обращения: 31.08.2018)
9. Подымова С. Д. Болезни печени: Руководство для врачей. М.; 2018. 984 [Podymova SD. Bolezni pecheni: Rukovodstvo dlya vrachei. Moscow: Medical information Agency; 2018].
10. Araújo Júnior RF de, Garcia VB, Leitão RF de C, Brito GA de C, Miguel E de C, Guedes PMM, et al. Carvedilol Improves Inflammatory Response, Oxidative Stress and Fibrosis in the AlcoholInduced Liver Injury in Rats by Regulating Kuppfer Cells and Hepatic Stellate Cells. Avila MA, editor. PLOS ONE. 2016 Feb 18;11(2):e0148868. doi: 10.1371/journal.pone.0148868
11. Brunt EM, Gouw ASH, Hubscher SG, Tiniakos DG, Bedossa P, Burt AD, et al. Pathology of the liver sinusoids. Histopathology. 2014 Mar 8;64(7):907–20. doi: 10.1111/his.12364
12. Elswefy SE-S, Abdallah FR, Atteia HH, Wahba AS, Hasan RA. Inflammation, oxidative stress and apoptosis cascade implications in bisphenol A-induced liver fibrosis in male rats. International Journal of Experimental Pathology. 2016 Oct;97(5):369–79. doi: 10.1111/iep.12207
13. Germani G, Burroughs AK, Dhillon AP. The relationship between liver disease stage and liver fibrosis: a tangled web. Histopathology. 2010 Aug 31;57(6):773–84. doi: 10.1111/j.1365-2559.2010.03609.x
14. Kanel GC. Pathology of liver diseases. Chichester, West Sussex: Wiley Blackwell; 2017.
15. Mourelle M, Favari L, Amezcua JL. Protection against thallium hepatotoxicity by Silymarin. Journal of Applied Toxicology. 1988 Oct;8(5):351–4. doi: 10.1002/jat.2550080503
16. Rasineni K, Penrice DD, Natarajan SK, McNiven MA, McVicker BL, Kharbanda KK, et al. Alcoholic vs non-alcoholic fatty liver in rats: distinct differences in endocytosis and vesicle trafficking despite similar pathology. BMC Gastroenterology. 2016 Feb 29;16(1). doi:10.1186/s12876-016-0433-4
17. Wang L, Huang Q-H, Li Y-X, Huang Y-F, Xie J-H, Xu L-Q, et al. Protective effects of silymarin on triptolide-induced acute hepatotoxicity in rats. Molecular Medicine Reports. 2017 Nov 3;17(1):789–800. doi: 10.3892/mmr.2017.7958
18. Xiao S-Y, Oshima K. Liver pathology. New York Demos Medical; 2015.
19. Zhang Y, Luo J, Hu X, Yang F, Zhong S, Lin W. Improved prescription of taohechengqi-tang alleviates D-galactosamine acute liver failure in rats. World Journal of Gastroenterology. 2016;22(8):2558–65. doi: 10.3748/wjg.v22.i8.2558
Review
For citations:
Myazin R.G., Snigur G.L., Emel'yanov D.N., Chernyshova M.V. Pharmacological Correction of Experimental Acute Toxic Hepatitis. Journal of Anatomy and Histopathology. 2019;8(1):49-54. (In Russ.) https://doi.org/10.18499/2225-7357-2019-8-1-49-54
Views:
551
Email this article 